Q/C Technologies, Inc. (QCLS): Net Income
-$11.63M
Year ended 2025-12-31
-$16.57M
Trailing 12 months to 2026-06-30
| Period ended | Net Income | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$11.63M | n/m | 2026-04-15, From 2025-01-01 |
| 2024-12-31 | -$23.36M | n/m | 2026-04-15, From 2024-01-01 |
| 2023-12-31 | -$4.00M | n/m | 2025-04-11, From 2023-01-01 |
| 2022-12-31 | -$15.20M | n/m | 2024-04-01, From 2022-01-01 |
| 2021-12-31 | -$29.89M | n/m | 2023-03-31, From 2021-01-01 |
| 2020-12-31 | -$9.49M | n/c | 2022-03-31, From 2020-01-01 |
| 2019-12-31 | -$3.89M | n/m | 2021-03-01, From 2019-01-01 |
| 2018-12-31 | -$10.85M | n/m | 2020-03-25, From 2018-01-01 |
| 2017-12-31 | -$7.37M | n/m | 2019-04-01, From 2017-01-01 |
| 2016-12-31 | -$3.30M | n/m | 2018-07-13, From 2016-01-01 |
| 2015-12-31 | -$9.31M | n/m | 2017-04-11, From 2015-01-01 |
| 2014-12-31 | -$3.14M | n/m | 2016-03-30, From 2014-01-01 |
| 2013-12-31 | -$1.53M | n/a | 2015-03-23, From 2013-01-01 |
Net Income at similar companies
| Company | Year ended | Net Income | Change YoY |
|---|---|---|---|
| Q/C Technologies, Inc. (QCLS) | 2025-12-31 | -$11.63M | n/m |
| Achieve Life Sciences, Inc. (ACHV) | 2025-12-31 | -$54.65M | n/m |
| Immucell Corp (ICCC) | 2025-12-31 | -$1.04M | n/m |
| Anbio Biotechnology (NNNN) | 2025-12-31 | $6.40M | +169.9% |
| Insight Molecular Diagnostics Inc. (IMDX) | 2025-12-31 | -$50.22M | n/m |
| Alpha Teknova, Inc. (TKNO) | 2025-12-31 | -$17.26M | n/m |
| Cardio Diagnostics Holdings, Inc. (CDIO) | 2025-12-31 | -$6.50M | n/m |
| Volitionrx Ltd (VNRX) | 2025-12-31 | -$23.36M | n/m |
| Biomerica Inc (BMRA) | 2026-05-31 | -$3.77M | n/m |
Compare QCLS, ACHV, ICCC, NNNN side by side · Screen every company in In Vitro & In Vivo Diagnostic Substances ↗